Female reproductive health after childhood, adolescent, and young adult cancers: Guidelines for the assessment and management of female reproductive complications

Journal of Clinical Oncology

Volumn 31, Issue 9, 2013, Pages 1239-1247

  Metzger, Monika L ^a,b   Meacham, Lillian R ^c   Patterson, Briana ^c   Casillas, Jacqueline S ^d   Constine, Louis S ^e   Hijiya, Nobuko ^f   Kenney, Lisa B ^h   Leonard, Marcia ⁱ   Lockart, Barbara A ^g   Likes, Wendy ^b   Green, Daniel M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTICLE; ESTROGEN THERAPY; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FERTILIZATION IN VITRO; GYNECOLOGIC DISEASE; HUMAN; HYPOGONADISM; INFERTILITY THERAPY; NEOPLASM; PRACTICE GUIDELINE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH;

ADOLESCENT; AFTERCARE; CHILD; ETHICS, MEDICAL; FEMALE; GONADAL DISORDERS; HUMANS; HYPOGONADISM; INFERTILITY, FEMALE; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PUBERTY, PRECOCIOUS; QUALITY OF LIFE; REPRODUCTIVE HEALTH; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; YOUNG ADULT;

EID: 84875981964     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.5511     Document Type: Article

References (147)

1. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004 (Pubitemid 46638624)
2. Children's Oncology Group: Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. http://www. survivorshipguidelines.org/
3. Landier W, Wallace WH, Hudson MM: Long-term follow-up of pediatric cancer survivors: Education, surveillance, and screening. Pediatr Blood Cancer 46:149-158, 2006 (Pubitemid 43076064)
4. Andrieu JM, Ochoa-Molina ME: Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 52: 435-438, 1983 (Pubitemid 13073467)
5. Schilsky RL, Sherins RJ, Hubbard SM, et al: Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 71:552-556, 1981 (Pubitemid 12140420)
6. Chemaitilly W, Mertens AC, Mitby P, et al: Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 91:1723-1728, 2006
7. Sklar CA, Mertens AC, Mitby P, et al: Premature menopause in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:890-896, 2006 (Pubitemid 44018918)
8. Sarafoglou K, Boulad F, Gillio A, et al: Go-nadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 130:210-216, 1997 (Pubitemid 27495155)
9. Sklar C: Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 33:2-8, 1999 (Pubitemid 29318657)
10. Damewood MD, Grochow LB: Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 45:443-459, 1986 (Pubitemid 16120641)
11. Wallace WH, Thomson AB, Kelsey TW: The radiosensitivity of the human oocyte. Hum Reprod 18:117-121, 2003 (Pubitemid 36138861)
12. Robison LL, Armstrong GT, Boice JD, et al: The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27:2308-2318, 2009
13. Byrne J: Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 33:24-28, 1999 (Pubitemid 29318660)
14. Chiarelli AM, Marrett LD, Darlington G: Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 150:245-254, 1999 (Pubitemid 29344950)
15. Sklar C: Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 34:25-27, 2005
16. Cramer DW, Xu H, Harlow BL: Does "incessant" ovulation increase risk for early menopause? Am J Obstet Gynecol 172:568-573, 1995
17. Bajorunas DR, Ghavimi F, Jereb B, et al: Endocrine sequelae of antineoplastic therapy in childhood head and neck malignancies. J Clin Endocrinol Metab 50:329-335, 1980 (Pubitemid 10161471)
18. Brauner R, Rappaport R: Precocious puberty secondary to cranial irradiation for tumors distant from the hypothalamo-pituitary area. Horm Res 22: 78-82, 1985
19. Rappaport R, Brauner R, Czernichow P, et al: Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 54:1164-1168, 1982 (Pubitemid 13238695)
20. Shalet SM, Beardwell CG, MacFarlane IA, et al: Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood. Acta Endocrinol (Copenh) 84:673-680, 1977 (Pubitemid 8164099)
21. Sklar CA, Constine LS: Chronic neuroendo-crinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113-1121, 1995
22. Constine LS, Woolf PD, Cann D, et al: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87-94, 1993
23. Byrne J, Fears TR, Mills JL, et al: Fertility in women treated with cranial radiotherapy for child-hood acute lymphoblastic leukemia. Pediatr Blood Cancer 42:589-597, 2004 (Pubitemid 38669746)
24. Nygaard R, Clausen N, Siimes MA, et al: Reproduction following treatment for childhood leukemia: A population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol 19:459-466, 1991
25. Green DM, Kawashima T, Stovall M, et al: Fertility of female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 27:2677-2685, 2009
26. Green DM, Nolan VG, Kawashima T, et al: Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pitu-itary irradiation: A report from the Childhood Cancer Survivor Study. Fertil Steril 95:1922-1927, 2011
27. Broekmans FJ, Soules MR, Fauser BC: Ovarian aging: Mechanisms and clinical consequences. Endocr Rev 30:465-493, 2009
28. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al: Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod 24:982-990, 2009
29. La Marca A, Sighinolfi G, Radi D, et al: Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16:113-130, 2010
30. Nelson SM, Messow MC, McConnachie A, et al: External validation of nomogram for the decline in serum anti-Mullerian hormone in women: A population study of 15,834 infertility patients. Reprod Biomed Online 23:204-206, 2011
31. Steiner AZ, Herring AH, Kesner JS, et al: Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 117:798-804, 2011
32. van Rooij IA, Broekmans FJ, Scheffer GJ, et al: Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 83:979-987, 2005
33. Visser JA, Schipper I, Laven JS, et al: Anti-Müllerian hormone: An ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 8:331-341, 2012
34. Sowers M, McConnell D, Gast K, et al: Anti-Mü llerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril 94:1482-1486, 2010
35. Hagen CP, Aksglaede L, Sørensen K, et al: Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 95:5003-5010, 2010
36. Bath LE, Wallace WH, Shaw MP, et al: Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mü llerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18:2368-2374, 2003 (Pubitemid 37427819)
37. Lutchman Singh K, Davies M, Chatterjee R: Fertility in female cancer survivors: Pathophysiol-ogy, preservation and the role of ovarian reserve testing. Hum Reprod Update 11:69-89, 2005 (Pubitemid 40201977)
38. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al: Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab 92:3869-3874, 2007 (Pubitemid 47607635)
39. Brougham MF, Crofton PM, Johnson EJ, et al: Anti-Müllerian hormone is a marker of gonado-toxicity in pre- and postpubertal girls treated for cancer: A prospective study. J Clin Endocrinol Metab 97:2059-2067, 2012
40. Hamre H, Kiserud CE, Ruud E, et al: Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross-sectional study. Pediatr Blood Cancer 59:271-277, 2012
41. Partridge AH, Ruddy KJ, Gelber S, et al: Ovarian reserve in women who remain premeno-pausal after chemotherapy for early stage breast cancer. Fertil Steril 94:638-644, 2010
42. Anderson RA, Cameron DA: Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 96:1336-1343, 2011
43. Loh JS, Maheshwari A: Anti-Mullerian hormone: Is it a crystal ball for predicting ovarian ageing? Hum Reprod 26:2925-2932, 2011
44. Yu B, Douglas N, Ferin MJ, et al: Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer 116:2099-2105, 2010
45. Davenport ML: Moving toward an understanding of hormone replacement therapy in adolescent girls: Looking through the lens of Turner syndrome. Ann N Y Acad Sci 1135:126-137, 2008 (Pubitemid 351862144)
46. Brydøy M, Fo̊ssa SD, Dahl O, et al: Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 46:480-489, 2007 (Pubitemid 46752258)
47. Cohen LE: Endocrine late effects of cancer treatment. Endocrinol Metab Clin North Am 34:769-789, 2005 (Pubitemid 41112097)
48. DiVasta AD, Gordon CM: Hormone replacement therapy for the adolescent patient. Ann N Y Acad Sci 1135:204-211, 2008 (Pubitemid 351862127)
49. Divasta AD, Gordon CM: Hormone replacement therapy and the adolescent. Curr Opin Obstet Gynecol 22:363-368, 2010
50. Meacham L: Endocrine late effects of childhood cancer therapy. Curr Probl Pediatr Adolesc Health Care 33:217-242, 2003 (Pubitemid 37063160)
51. Cohen LE: Cancer treatment and the ovary: The effects of chemotherapy and radiation. Ann N Y Acad Sci 1135:123-125, 2008 (Pubitemid 351862136)
52. Wallace WH, Anderson RA, Irvine DS: Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol 6:209-218, 2005 (Pubitemid 40450712)
53. Kenney LB, Yasui Y, Inskip PD, et al: Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 141:590-597, 2004 (Pubitemid 39390536)
54. van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980, 2003 (Pubitemid 36896714)
55. Herman-Giddens ME, Slora EJ, Wasserman RC, et al: Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings Network. Pediatrics 99:505-512, 1997
56. Euling SY, Herman-Giddens ME, Lee PA, et al: Examination of US puberty-timing data from 1940 to 1994 for secular trends: Panel findings. Pediatrics 121:S172-S191, 2008 (suppl 3)
57. Kaplowitz PB: Treatment of central precocious puberty. Curr Opin Endocrinol Diabetes Obes 16:31-36, 2009
58. Rosenfield RL, Bachrach LK, Chernausek SD, et al: Current age of onset of puberty. Pediatrics 106:622-623, 2000
59. Chow EJ, Friedman DL, Yasui Y, et al: Timing of menarche among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 50:854-858, 2008 (Pubitemid 351356099)
60. Oberfield SE, Soranno D, Nirenberg A, et al: Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Ado-lesc Med 150:589-592, 1996 (Pubitemid 26196768)
61. Ogilvy-Stuart AL, Clayton PE, Shalet SM: Cranial irradiation and early puberty. J Clin Endocrinol Metab 78:1282-1286, 1994 (Pubitemid 24180992)
62. Quigley C, Cowell C, Jimenez M, et al: Normal or early development of puberty despite gonadal damage in children treated for acute lym-phoblastic leukemia. N Engl J Med 321:143-151, 1989 (Pubitemid 19180677)
63. Carel JC, Leger J: Clinical practice: Precocious puberty. N Engl J Med 358:2366-2377, 2008
64. Mul D, Hughes IA: The use of GnRH agonists in precocious puberty. Eur J Endocrinol 159:S3-S8, 2008 (suppl 1)
65. Carel JC, Lahlou N, Roger M, et al: Precocious puberty and statural growth. Hum Reprod Update 10:135-147, 2004 (Pubitemid 38519334)
66. Neely EK, Hintz RL, Parker B, et al: Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr 121:634-640, 1992
67. Arrigo T, Cisternino M, Galluzzi F, et al: Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 141:140-144, 1999 (Pubitemid 29402217)
68. Carel JC, Eugster EA, Rogol A, et al: Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123:e752-e762, 2009
69. Oostdijk W, Rikken B, Schreuder S, et al: Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 75:292-297, 1996 (Pubitemid 26354598)
70. Tucker MA, Meadows AT, Boice JD Jr, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987 (Pubitemid 17036759)
71. Green DM, Sklar CA, Boice JD Jr, et al: Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol 27:2374-2381, 2009
72. Wo JY, Viswanathan AN: Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73:1304-1312, 2009
73. Blatt J: Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 33:29-33, 1999 (Pubitemid 29318661)
74. Byrne J, Mulvihill JJ, Connelly RR, et al: Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Med Pedi-atr Oncol 16:233-240, 1988
75. Green DM, Lange JM, Peabody EM, et al: Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor Long-term Follow-up Study. J Clin Oncol 28:2824-2830, 2010
76. Thibaud E, Ramirez M, Brauner R, et al: Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 121:880-884, 1992
77. Clough KB, Goffinet F, Labib A, et al: Lapa-roscopic unilateral ovarian transposition prior to irradiation: Prospective study of 20 cases. Cancer 77: 2638-2645, 1996
78. Damewood MD, Hesla HS, Lowen M, et al: Induction of ovulation and pregnancy following lateral oophoropexy for Hodgkin's disease. Int J Gynaecol Obstet 33:369-371, 1990 (Pubitemid 20345128)
79. Zinger M, Liu JH, Husseinzadeh N, et al: Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy. J Re-prod Med 49:573-574, 2004 (Pubitemid 38944246)
80. Lee SJ, Schover LR, Partridge AH, et al: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931, 2006 (Pubitemid 46655598)
81. Lass A: The fertility potential of women with a single ovary. Hum Reprod Update 5:546-550, 1999 (Pubitemid 29512141)
82. Levitas E, Furman B, Shoham-Vardi I, et al: Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET). Eur J Obstet Gynecol Reprod Biol 88:197-200, 2000 (Pubitemid 30004061)
83. Wallberg KA, Keros V, Hovatta O: Clinical aspects of fertility preservation in female patients. Pediatr Blood Cancer 53:254-260, 2009
84. Kuohung W, Ram K, Cheng DM, et al: Lapa-roscopic oophoropexy prior to radiation for pediatric brain tumor and subsequent ovarian function. Hum Reprod 23:117-121, 2008 (Pubitemid 351767335)
85. Terenziani M, Piva L, Meazza C, et al: Oo-phoropexy: A relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril 91: 935.e15-935.e16, 2009
86. Badawy A, Elnashar A, El-Ashry M, et al: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil Steril 91:694-697, 2009
87. Falorio S, Angrilli F, Fioritoni G: Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma. Leuk Lymphoma 49:1087-1093, 2008 (Pubitemid 351943254)
88. Blumenfeld Z, Dann E, Avivi I, et al: Fertility after treatment for Hodgkin's disease. Ann Oncol 13:138-147, 2002 (suppl 1) (Pubitemid 34567418)
89. Blumenfeld Z, Avivi I, Eckman A, et al: Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166-173, 2008
90. Dann EJ, Epelbaum R, Avivi I, et al: Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophos-phamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Hum Reprod 20:2247-2249, 2005 (Pubitemid 41418514)
91. Del Mastro L, Catzeddu T, Boni L, et al: Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17:74-78, 2006 (Pubitemid 43033843)
92. Del Mastro L, Boni L, Michelotti A, et al: Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial. JAMA 306:269-276, 2011
93. Oktay K, Sönmezer M, Oktem O, et al: Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12:1055-1066, 2007 (Pubitemid 350007017)
94. Pereyra PB, Méndez Ribas JM, Milone G, et al: Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: A preliminary report. Gy-necol Oncol 81:391-397, 2001 (Pubitemid 32494652)
95. Recchia F, Saggio G, Amiconi G, et al: Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106:514-523, 2006 (Pubitemid 43157613)
96. Behringer K, Wildt L, Mueller H, et al: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma: Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol 21:2052-2060, 2010
97. Munster PN, Moore AP, Ismail-Khan R, et al: Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol 30:533-538, 2012
98. Waxman JH, Ahmed R, Smith D, et al: Failure to preserve fertility in patients with Hodg-kin's disease. Cancer Chemother Pharmacol 19:159-162, 1987 (Pubitemid 17059373)
99. Blumenfeld Z, von Wolff M: GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543-552, 2008
100. Imai A, Sugiyama M, Furui T, et al: Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol Obstet Invest 63:102-106, 2007
101. Zelinski MB, Murphy MK, Lawson MS, et al: In vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates. Fertil Steril 95:1440-1445, 2011
102. Domingo J, Ayllón Y, Domingo S, et al: New approaches to female fertility preservation. Clin Transl Oncol 11:154-159, 2009
103. Donnez J, Dolmans MM: Cryopreservation of ovarian tissue: An overview. Minerva Med 100: 401-413, 2009
104. Oktay K, Karlikaya G: Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342:1919, 2000 (Pubitemid 30419063)
105. Donnez J, Dolmans MM, Demylle D, et al: Livebirth after orthotopic transplantation of cryopre-served ovarian tissue. Lancet 364:1405-1410, 2004 (Pubitemid 39370715)
106. Meirow D: Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 169: 123-131, 2000 (Pubitemid 32063311)
107. Meirow D, Levron J, Eldar-Geva T, et al: Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318-321, 2005 (Pubitemid 41058339)
108. Smitz J, Dolmans MM, Donnez J, et al: Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: Implications for fertility preservation. Hum Reprod Update 16:395-414, 2010
109. Köhler TS, Kondapalli LA, Shah A, et al: Results from the survey for preservation of adolescent reproduction (SPARE) study: Gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 28:269-277, 2011
110. Rodriguez AO: Fertility in cancer survivors. Curr Opin Obstet Gynecol 22:1-2, 2010
111. Jeruss JS, Woodruff TK: Preservation of fertility in patients with cancer. N Engl J Med 360:902-911, 2009
112. Rosen A: Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 34:91-93, 2005
113. Anselmo AP, Cavalieri E, Aragona C, et al: Successful pregnancies following an egg donation program in women with previously treated Hodg-kin's disease. Haematologica 86:624-628, 2001 (Pubitemid 32601106)
114. Kelly J, Hughes CM, Harrison RF: The hidden costs of IVF. Ir Med J 99:142-143, 2006
115. Duffy C, Allen S: Medical and psychosocial aspects of fertility after cancer. Cancer J 15:27-33, 2009
116. Oosterhuis BE, Goodwin T, Kiernan M, et al: Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer 50:85-89, 2008 (Pubitemid 350234270)
117. Schover LR, Rybicki LA, Martin BA, et al: Having children after cancer: A pilot survey of survivors' attitudes and experiences. Cancer 86:697-709, 1999 (Pubitemid 29379417)
118. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L: Psychosocial distress in young cancer survivors. Semin Oncol Nurs 25:268-277, 2009
119. Skinner R, Wallace WH, Levitt GA: Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 7:489-498, 2006 (Pubitemid 44207842)
120. Wenzel L, Dogan-Ates A, Habbal R, et al: Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr 34:94-98, 2005
121. Robertson JA: Cancer and fertility: Ethical and legal challenges. J Natl Cancer Inst Monogr 34:104-106, 2005
122. Fertility preservation and reproduction in cancer patients. Fertil Steril 83:1622-1628, 2005
123. Shaddy RE, Denne SC: Clinical report: Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 125:850-860, 2010
124. Burns KC, Boudreau C, Panepinto JA: Attitudes regarding fertility preservation in female adolescent cancer patients. J Pediatr Hematol Oncol 28:350-354, 2006 (Pubitemid 43970390)
125. Schover LR: Rates of postcancer parenthood. J Clin Oncol 27:321-322, 2009
126. Schover LR: Patient attitudes toward fertility preservation. Pediatr Blood Cancer 53:281-284, 2009
127. Nagarajan R, Robison LL: Pregnancy outcomes in survivors of childhood cancer. J Natl Cancer Inst Monogr 34:72-76, 2005
128. Winther JF, Boice JD Jr, Frederiksen K, et al: Radiotherapy for childhood cancer and risk for congenital malformations in offspring: A population-based cohort study. Clin Genet 75:50-56, 2009
129. Signorello LB, Mulvihill JJ, Green DM, et al: Congenital anomalies in the children of cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 30:239-245, 2012
130. Winther JF, Olsen JH, Wu H, et al: Genetic disease in the children of Danish survivors of childhood and adolescent cancer. J Clin Oncol 30:27-33, 2012
131. Towner D, Loewy RS: Ethics of preimplantation diagnosis for a woman destined to develop early-onset Alzheimer disease. JAMA 287:1038-1040, 2002 (Pubitemid 34252064)
132. Armstrong GT, Liu Q, Yasui Y, et al: Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328-2338, 2009
133. Gurney JG, Kadan-Lottick NS, Packer RJ, et al: Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97:663-673, 2003 (Pubitemid 36125844)
134. Hudson MM, Mertens AC, Yasui Y, et al: Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 290:1583-1592, 2003 (Pubitemid 37430383)
135. Mertens AC, Yasui Y, Liu Y, et al: Pulmonary complications in survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study. Cancer 95:2431-2441, 2002 (Pubitemid 35351152)
136. Spunt SL, Sweeney TA, Hudson MM, et al: Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 23:7143-7151, 2005
137. Zantomio D, Grigg AP, MacGregor L, et al: Female genital tract graft-versus-host disease: Incidence, risk factors and recommendations for management. Bone Marrow Transplant 38:567-572, 2006 (Pubitemid 44509550)
138. El-Toukhy TA, Hefni M, Davies A, et al: The effect of different types of hysterectomy on urinary and sexual functions: A prospective study. J Obstet Gynaecol 24:420-425, 2004 (Pubitemid 38824096)
139. Sarrel PM: Sexuality and menopause. Obstet Gynecol 75:26S-30S, 1990 (suppl) (Pubitemid 20120737)
140. Schoen C, Bachmann G: Sildenafil citrate for female sexual arousal disorder: A future possibility? Nat Rev Urol 6:216-222, 2009
141. Derzko C, Elliott S, Lam W: Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 14:S20-S40, 2007 (suppl 1)
142. Andersen BL, Anderson B, deProsse C: Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol 57:683-691, 1989 (Pubitemid 20082690)
143. Rosen R, Brown C, Heiman J, et al: The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191-208, 2000 (Pubitemid 30194541)
144. Schover LR: Sexuality and Fertility After Cancer. New York, NY, Wiley, 1997
145. Gallo-Silver L: The sexual rehabilitation of persons with cancer. Cancer Pract 8:10-15, 2000 (Pubitemid 30060902)
146. Stratton P, Turner ML, Childs R, et al: Vulvo-vaginal chronic graft-versus-host disease with allo-geneic hematopoietic stem cell transplantation. Obstet Gynecol 110:1041-1049, 2007 (Pubitemid 350059409)
147. Brotto LA, Heiman JR, Goff B, et al: A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav 37:317-329, 2008 (Pubitemid 351423078)